2022 COVID-19 Testing Market Update Report – COVID-19 Drives Molecular Point of Care Growth – ResearchAndMarkets.com | Region
DUBLIN–(Enterprise WIRE)–May 11, 2022–
The “COVID-19 Tests Marketplace Update, 2022” report has been additional to ResearchAndMarkets.com‘s giving.
This report, COVID-19 Tests Market Update, 2022, presents current market sizing and estimates for COVID-19 exams with some discussion of current market impacts of COVID-19.
Corporations Stated
- Abbott Laboratories
- Becton Dickinson
- bioMerieux
- Danaher Company
- Hologic
- Qiagen
- Quidel Corporation
- Roche Diagnostics
- Siemens
- Thermo Fisher Scientific
The scourge of COVID-19 continued to occupy laboratories and the in vitro diagnostic (IVD) corporations that serve them during 2021 and into 2022. Screening presently current in massive labs and clinics entered the home final calendar year, which added to industry revenues.
At the time of publication, there is a slight minimize in situations which might propose a lessen in COVID-19 tests revenues, but we have been via this right before. Predicting COVID-19 is not quick. For the earlier two several years, the sickness has confounded prediction. There are at the very least two universities of considered about 2022. One is that COVID, as a outcome of the extremely contagious Omicron and Delta variants, uncovered more than enough of the population to have antibodies, and this together with solid vaccination rates and boostering, makes COVID-19 a nonetheless existing but waning disorder. Even in this optimistic scenario, screening will be at substantial volume and stays required throughout 2022, but there would be a decrease in revenues.
A extra pessimistic disease situation would be that there are other variants that prove to be contagious, and vaccines do not provide plenty of prolonged term defense and the populace isn’t boostering at superior ranges. This would signify another wave like that observed during Q4 2021 and could possibly suggest that these kinds of waves will be with us for some time. The next circumstance obviously would develop COVID-19 screening revenues and volumes higher than 2021.
Crucial Subject areas Protected:
Chapter 1: Govt Summary
- COVID-19 Tests Sector Need and Expansion
- Development Outlook
- State Distribution
- Exam Improvements and Approvals
Chapter 2: Trends and Developments
- Antigen and Molecular Item Developments
- Antigen
- Molecular
- Other Developments
- COVID-19 Screening Expands Multiplex Tests
- COVID-19 Drives Molecular Level of Treatment Expansion
- AI Mines CT, Lab Results to Forecast COVID-19 Severity
- Very long COVID Can Be Predicted Early On
- Spectroscopy Used in COVID-19
Chapter 3: Sector Evaluation COVID Testing
- Marketplace Analysis: Molecular, Antigen, Antibody and Rapid Tests
- COVID-19 Examination Marketplace Share
- COVID-19 Exam Sector by Country
- US, Canada, Japan, Africa / Middle East, Relaxation of World)
Chapter 4: Top rated IVD Market Individuals
For extra information about this report go to https://www.researchandmarkets.com/r/vuq2st
Check out supply version on businesswire.com:https://www.businesswire.com/news/dwelling/20220511005592/en/
Get in touch with: ResearchAndMarkets.com
Laura Wood, Senior Push Supervisor
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Contact 1-800-526-8630
For GMT Place of work Hrs Connect with +353-1-416-8900
Key word:
Industry Keyword: Overall health INFECTIOUS Diseases
Resource: Study and Marketplaces
Copyright Small business Wire 2022.
PUB: 05/11/2022 07:15 AM/DISC: 05/11/2022 07:17 AM
http://www.businesswire.com/information/home/20220511005592/en
Copyright Company Wire 2022.
